Merck KGaA, Darmstadt, Germany Granted 20 CRISPR Patents Total Worldwide

Merck KGaA, Darmstadt, Germany today announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices allowing its Life Science business’ patent… 19 AUG 2019 | DARMSTADT, GERMANY Patent offices in Europe, Israel, South Korea and U.K. issue seven additional grants for company’s CRISPR genome-editing technology Company has 20 allowed CRISPR patents... Read more

Merck KGaA, Darmstadt, Germany Granted 20 CRISPR Patents Total Worldwide

19 AUG 2019 | DARMSTADT, GERMANY Patent offices in Europe, Israel, South Korea and U.K. issue seven additional grants for company’s CRISPR genome-editing technology Company has 20 allowed CRISPR patents to date across nine different geographies Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the European, Israeli, South Korean and U.K. intellectual... Read more

GE Healthcare Partnership Takes Aim at Brain Aneurysms with AI

SYDNEY- August 9, 2019 –GE Healthcare, Fujitsu Australia, Macquarie University and Macquarie Medical Imaging today announced announced a new research collaboration to diagnose and monitor brain aneurysms on scans faster and more efficiently using artificial intelligence (AI) . The project has already received a Cooperative Research Centres Projects (CRC-P) grant of AU$2.1M from the Department... Read more

Enzo Biochem, Inc. Announces Issuance of United States Patent for Advanced Nucleic Acid Hybridization Probe Technology for Clinical and Research Applications

Transformative Development in Diagnostic Testing, Drug Development and Academic Research Marketplace Provides a Simple, Cost Effective and Scalable Process — — New Probe Technology Advances Company’s Ability to Offer Lower-Cost High-Performance Products and Services in the Clinical Diagnostics Market NEW YORK, NY, August 5, 2019 — Enzo Biochem, Inc. (NYSE: ENZ), an integrated diagnostics and... Read more

SAVSU Technologies Expands IP Portfolio with Risk Mitigation Technologies for Shipping Cell and Gene Therapies

Reduced in-transit shipping damage, Extended dynamic thermal performance and Predictive Analytics in Next Generation Dry Vapor Liquid Nitrogen Shippers BOTHELL, Wash., July 30, 2019 /PRNewswire/ —BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best in class bioproduction tools for cell and gene therapies, today announced that SAVSU Technologies, a leading developer of advanced... Read more

AOAC approves Neogen’s Reveal® Q+ for DON

CONTACT: Mary Gadola, Neogen Corporation, 517/372-9200 LANSING, Mich., Aug. 1, 2019 — Neogen Corporation (Nasdaq: NEOG) has received Performance TestedSM Method Certification from the AOAC Research Institute for its Reveal® Q+ for Deoxynivalenol (DON) test, which is designed for the rapid quantification of the mold toxin in grains. The AOAC approval (No. 071901) follows the earlier verification of the test’s... Read more

Agilent Settles Key Intellectual Property Case in China

Agilent Settles Key Intellectual Property Case in China EChrom and Pannatek Admit to using Agilent Technology Without Permission, Agree to Pay Damages and Cease Using Agilent Technology SANTA CLARA, Calif., July 31, 2019 Agilent Technologies, Inc. (NYSE: A) today announced that the company has reached agreement with China-based companies EChrom and Pannatek, as well as... Read more

Agilent Settles Key Intellectual Property Case in China

EChrom and Pannatek Admit to using Agilent Technology Without Permission, Agree to Pay Damages and Cease Using Agilent Technology SANTA CLARA, Calif., July 31, 2019 Agilent Technologies, Inc. (NYSE: A) today announced that the company has reached agreement with China-based companies EChrom and Pannatek, as well as certain former Agilent employees, regarding an intellectual property... Read more